TrialNeurology2025

Long-Term Treatment With Ocrelizumab in Patients With Early-Stage Relapsing MS: Nine-Year Data From the OPERA Studies Open-Label Extension.

João J Cerqueira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.